After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...
Published in the journal Endoscopy, the study compared two non-surgical obesity treatments in 150 adults treated between January 2024 and April 2025.
Alternative to Meds Center has expanded its educational resources on Caplyta side effects. Whenever a newer medication ...
Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney ...
In addition to high-stakes U.S. House races, California voters in November will also weigh in on a slew of ballot measures.
Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of ...
Experts weigh in.
What do Botox, rat poison, weight-loss drugs and a fictional murder investigation have in common? At the University of Nevada ...
Replimune Group, Inc. nears a pivotal FDA AdCom for RP1 ahead of an Aug 2, 2026 decision. Click for this REPLY stock update ...
Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...
Proceeds will fund advancement of ARON degrader, FX-111, to proof of concept and preclinical development of ARON RIPTAC program- Veteran ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results